Back

Sirtuin-1 prevents perivascular adipose tissue inflammation via adiponectin/adiponectin receptor-2 axis

1 September 2025 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Targeting vascular inflammation, remodelling, and haemodynamics in hypertension and aortic aneurysms Vascular Biology and Physiology ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Srividya Velagapudi

University of Zurich, Zurich (Switzerland)

7 More presentations in this session

Presentation thumbnail
Role of heterogeneous nuclear ribonucleoprotein A1 in proteomic remodeling before and after plexiform lesion formation in the Sugen/hypoxia rat model
Doctor Y. Morimoto (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Cannabigerol as a vasodilatory and blood pressure-lowering agent in spontaneously hypertensive rats
Doctor A. Krzyzewska (Bialystok, PL)
Abstract Slides Video
Presentation thumbnail
Rapid prediction of pulsatile hemodynamics in the aortic arch based on physics-informed neural networks
Mr X. Zhang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
NAT10 promotes aortic aneurysms through lysine acetylation modification
Doctor C. Yu (Fuzhou, CN)
Abstract Slides Video
Presentation thumbnail
Exploring adventitial pericyte dysfunction and MEK/ERK signalling as therapeutic targets in thoracic aortic aneurysm
Doctor K. Mohammed (Bristol, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Targeting vascular inflammation, remodelling, and haemodynamics in hypertension and aortic aneurysms

The Event

Event poster

ESC Congress 2025

1 September 2025 08:15 CET
You may be interested in
thumbnail
Congress Presentation
The bidirectional interplay between perivascular adipose tissue in atherosclerotic cardiovascular disease
thumbnail
Congress Session
Metabolic reprogramming and crosstalk in cardiometabolic and vascular disease
thumbnail
Congress Presentation
Elevated inflammation of perivascular adipose tissue in type 2 diabetic patients versus non-diabetic controls: insights from a retrospective CCT study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources